Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (486)	1/22/2000 9:06:00 PM
From: scaram(o)uche	Respond to of 673

>> Sounds like the people at Penn are/were running a pretty low quality operation << Ugh. Ugh, ugh, ugh, ugh. Thanks, Jim. Rick

To: Jim Oravetz who wrote (486)	2/2/2000 1:00:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 673

Earlier Gene Test Deaths Not Reported NIH Was Unaware Of 'Adverse Events' By Deborah Nelson and Rick Weiss Washington Post Staff Writers Monday, January 31, 2000 A Harvard-affiliated hospital in Boston quietly suspended a gene therapy experiment last summer after three of the first six patients died and a seventh fell seriously ill, previously unreleased research records show. www.washingtonpost.com/wp-srv/WPlate/2000-01/31/128l-013100-idx.html Jim